EDGE
Book a demo

Fertility Tech

Long-term demographic changes are finally bringing fertility technologies into focus.

Overview

Apps and services aimed at fertility tracking, monitoring, and preservation

Fertility tech refers to technology driven solutions used by men and women to monitor or preserve fertility. Fertility monitoring helps couples increase their chance of conceiving. Fertility preservation reduces the impact of one’s biological clock when making decisions on conceiving and family planning. The fertility tech ecosystem also includes players who support the fertility tech industry by offering patients assistance in navigating their fertility care decision-making and financing. These tech tools are gaining traction supported by several demographic, social, and economic factors such as delaying parenthood, decreasing male fertility, and a shortage of fertility clinics.

What's driving this industry?
Market Sizing

Fertility tech market in the US estimated to range between USD 1.9-3.2 billion by 2025

Conservative case

USD 1.9 Bn

Base case

USD 2.5 Bn

Expansion case

USD 3.2 Bn

USD billion01234202020212022202320242025
View details

COVID-19 IMPACT

  • Fertility preservation services such as egg and sperm freezing face elevated near-term demand due to an increase in uncertainty caused by the pandemic.

  • Fertility test kits for men and women face supply chain challenges and potentially reduced demand as family formation and expansion tends to decline during periods of economic uncertainty. 

  • Fertility tracking and monitoring apps expected to remain largely unaffected by the pandemic.

  • Natural Cycles and Ava have added features to monitor Covid-19 symptoms among their users. 

Market Mapping

The fertility tech market primarily includes products engaged in fertility monitoring and tracking, which includes at-home fertility/hormone measuring kits, fertility and ovulation monitoring and tracking app, and the men’s fertility test and sperm storage segments as well as fertility preservation services. Notably, among the disruptors and watchlist companies, egg freezing services had the smallest number of companies.

Most firms in the industry are pure-play companies, with the exception of leading disruptors EverlyWell, Kindbody, and Prelude Fertility. Around half of the disruptors and watchlist companies identified in this report are early stage, with the remainder split between seed and growth stages.

Incumbents
Growth
Early
Seed
Pre-Seed
Women's at-home fertility/hormone measuring kit
?
Period and fertility monitoring and tracking app
?
Egg freezing services and storage
?
Men's fertility test and sperm storage
?
Fertility service access providers and others
?
LetsGetChecked
LetsGetChecked
LetsGetChecked
LetsGetChecked
LetsGetChecked
EarlySense
Ro (Modern Fertility)
Advanced Medical Services
Everly Health
LetsGetChecked
Natural Cycles
Prima Temp
OvuSense (Fertility Focus)
Inne
Hertility Health
Mira
Mosie Baby
Proov
Kegg
Eli
Oova
Layla Wellness
Google
Flo
Clue
Ava
Glow
Fertility Friend
WOOM
Conceivable
Posy
Bea Fertility
Layla Wellness
Google
Carolinas Fertility Institute
HRC Fertility Clinics
CCRM Fertility
Sher Fertility Solutions - New York
Prelude Fertility
TMRW
Kindbody
Extend Fertility
Mate Fertility
Overture Life
Lilia
Future Fertility
DNA Diagnostics Center
Sandstone
Carolinas Fertility Institute
HRC Fertility Clinics
CCRM Fertility
Everly Health
Prelude Fertility
Legacy
Dadi
ExSeed
Mate Fertility
Sppare
Fellow
YO
Kindbody
Progyny
Carrot Fertility
Future Family
Stork Club
Univfy
She's Well
Kentucky Fertility Institute
FertilityIQ
Alife Health
Hannah Life Technology
Fertifa
Bea Fertility
Cycle Clarity

The Disruptors

Integrated players EverlyWell and Prelude Fertility remain highest funded, followed by financial assistance players

While most disruptors cater to a single segment in the fertility tech ecosystem, one of the highest funded disruptors, Prelude Fertility, distinguishes itself by offering a range of services. Prelude’s offering includes sperm and egg freezing, embryo creation and transfer, and genetic screening for inherited diseases and abnormalities. The highest funded disruptor in this space as of August 2021 was fertility test kit provider, EverlyWell.

Most disruptors compete with their segmental peers with similar products, with the exception of at-home fertility/hormone measuring kits for women, where different bodily components are used to measure hormones. For instance, Natural Cycles uses temperature to measure ovulation, whereas Kegg measures cervical fluids to track hormone levels. Furthermore, WOOM is an exception to most period and fertility monitoring apps, as it looks to track and give more information on bodily functions, while other apps typically look to predict future cycles using the data.

Women's at-home fertility/hormone measuring kit

?

Disruptors

?
Funding in USD Millions
LetsGetChecked
263
Natural Cycles
38
Prima Temp
12
OvuSense (Fertility Focus)
10
Watchlist
?
Proov
Inne
Hertility Health
Kegg
Mira
Eli
Oova
Layla Wellness
Mosie Baby

Period and fertility monitoring and tracking app

?

Disruptors

?
Funding in USD Millions
Flo
76
Clue
48
Ava
42
Glow
23
Fertility Friend
Unknown
Watchlist
?
WOOM
Bea Fertility
Conceivable
Layla Wellness
Posy

Egg freezing services and storage

?

Disruptors

?
Funding in USD Millions
Prelude Fertility
200
TMRW
154
Kindbody
125
Overture Life
45
Extend Fertility
15
Watchlist
?
Mate Fertility
Lilia
Future Fertility

Men's fertility test and sperm storage

?

Disruptors

?
Funding in USD Millions
Prelude Fertility
200
Legacy
20
Dadi
10
YO
Unknown
Watchlist
?
ExSeed
Mate Fertility
Sppare
Fellow

Fertility service access providers and others

?

Disruptors

?
Funding in USD Millions
Progyny
Public - Market cap USD 5.1 bn
Kindbody
125
Future Family
123
Carrot Fertility
114
Stork Club
33
Univfy
13
FertilityIQ
Unknown
Watchlist
?
Alife Health
She's Well
Hannah Life Technology
Fertifa
Bea Fertility
Cycle Clarity
Kentucky Fertility Institute

LetsGetChecked

Headquartered in Dublin and New York, LetsGetChecked (LGC) offers more than 100 at-home healthcare test kits for fertility, cholesterol, diabetes, thyroid, and Covid-19, among others. It provides the test results online and offers follow-up care through its telehealth and pharmacy offerings. As of June 2021, the company claimed to serve over 300 corporate customers, with over 2 million tests administered across the US and EU since its inception in 2015.

In the fertility tech space, the company offers two types of finger-prick test kits (a progesterone test and an ovarian reserve test) that allow samples to be gathered at home, later being mailed to the lab for analysis. The progesterone test assesses whether ovulation has occurred, and the ovarian reserve test measures the Anti-Mullerian Hormone (AMH) to indicate the number of a woman’s remaining eggs. LGC benefited from the Covid-19 pandemic promoting at-home healthcare and claims its revenue grew 1,500% YoY owing to the pandemic.

In June 2021, the company raised USD 150 million in Series D funding led by Casdin Capital, reaching unicorn status with a valuation of over USD 1 billion. The funds will be used to expand internationally and strengthen its telehealth services, pharmacy capabilities, and at-home testing.

Segment:
Women's at-home fertility/hormone measuring kit
Total funding:
USD 263.0 million
Competitors:
EverlyWell
Disruptor Funding History

Women's at-home fertility/hormone measuring kit:

LetsGetChecked
Natural Cycles
Prima Temp
OvuSense (Fertility Focus)
Proov
Inne
Hertility Health
Kegg
Mira
Eli
Oova
Layla Wellness

Period and fertility monitoring and tracking app:

Flo
Clue
Ava
Glow
WOOM
Bea Fertility
Conceivable
Layla Wellness

Egg freezing services and storage :

The Incumbents

Healthcare enterprises offer fertility tech products as extensions to their current offerings; Google has exposure via Fitbit

Incumbents in the fertility tech market include fertility clinics, medical device manufacturers, and testing kit providers. These companies generally opt to produce their own in-house innovations for the fertility tech market, as an extension of their current products and services. For instance, EarlySense offers a range of healthcare monitoring devices and also produces a device to monitor hormones and fertility for women.

DNA Diagnostics Center, a DNA diagnostics and testing provider, acquired Sperm Check in May 2018 to expand their testing to the fertility industry.

In addition to the healthcare enterprises, Google also has interests within the fertility tech industry, through subsidiary Fitbit’s wearables, which offers fertility tracking products, and has invested in a disruptor KindBody, an egg freezing service provider.

In-house development

Acquisition

Investment

Partnerships

company-logo-0Google
check
check
company-logo-1EarlySense
check
company-logo-2DNA Diagnostics Center
check
company-logo-3Sandstone
check
company-logo-4Carolinas Fertility Institute
check
company-logo-5HRC Fertility Clinics
check
company-logo-6CCRM Fertility
check
check
company-logo-7Sher Fertility Solutions - New York
check
company-logo-8Ro (Modern Fertility)
check
company-logo-9Advanced Medical Services
check
company-logo-10Everly Health
check
Google

Google’s subsidiary Fitbit (acquired in November 2019) launched a period and fertility tracking feature to its wearables in early 2018, which has been available to all Fitbit app users since Q2 2018. Similar to the disruptor offerings, the platform allows women to enter data from each menstrual cycle, which is then used to predict future cycles and fertility periods. 

In addition to the in-house offering through Fitbit, Google has also invested in Kindbody. Alphabet’s GV participated in Kindbody’s Series B funding in July 2020, and led its Series A funding in December 2019. Moreover, Spanish startup WOOM (offers a fertility tracking app) began at Google for Startups (Madrid) with the assistance from accelerator programs including Google Campus Residency.

Notable Investors

No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Unlock company details, featured industry reports, and news updates.
Book a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.